[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100267466":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":11,"centralContacts":15,"locations":22,"responsibleParty":44,"collaborators":47,"id":51,"slug":10,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":10,"eligibilityCriteria":56,"healthyVolunteers":52,"sex":57,"minAge":58,"maxAge":10,"enrollmentInfo":59,"targetDuration":10,"studyType":62,"phases":10,"briefSummary":63,"conditions":64,"keywords":10,"overallStatus":25,"whyStopped":10,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"SEARCH Research Foundation","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":10},"volunteer who completion of a recent ATI",null,[12],{"name":13,"affiliation":5,"role":14},"Somchai Sriplienchan, MD, MPH","PRINCIPAL_INVESTIGATOR",[16,19],{"name":13,"role":17,"phone":10,"phoneExt":10,"email":18},"CONTACT","somchai.s@searchthailand.org",{"name":20,"role":17,"phone":10,"phoneExt":10,"email":21},"Nitiya Chomchey, PhD","nitiya.c@searchthailand.org",[23],{"facility":24,"status":25,"city":26,"state":26,"zip":27,"country":28,"countryCode":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"SEARCH","RECRUITING","Bangkok","10330","Thailand","TH",{"type":31,"coordinates":32},"Point",[33,34],100.50144,13.75398,{"lat":34,"lon":33},[37,41],{"name":38,"role":17,"phone":39,"phoneExt":10,"email":40},"Nittaya - Phanuphak, MD, PhD","+6622542566","nittaya.p@trcarc.org",{"name":42,"role":17,"phone":39,"phoneExt":43,"email":21},"Nitiya - Chomchey, MSc","111",{"type":14,"investigatorFullName":45,"investigatorTitle":46,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Somchai Sriplienchan, MD","Somchai Sriplienchan MD MPH",[48],{"name":49,"class":50},"US Military HIV Research Program","NETWORK","100267466",false,"NCT02761200","Post Analytic Treatment Interruption Study","Safety and Virologic Outcomes After HIV Remission Trials in Patients Who Initiated Antiretroviral Therapy During Early Acute HIV Infection","Inclusion Criteria:\n\n* Man or woman aged ≥18 years.\n* Enrolled in RV254 study.\n* Completed clinical research protocol that included ATI within one month of enrollment in this protocol.\n* Able and willing to provide written informed consent or, in the case of illiteracy, witnessed verbal informed consent with documentation of a thumbprint in lieu of a signature.\n* Able to participate in study visits for up to 144 weeks.\n* Willing to have photo or fingerprint taken for identification purposes.\n* Female-specific criteria: Agrees not to become pregnant while not receiving ART. If a woman is sexually active and has no history of hysterectomy or tubal ligation or menopause, she must agree to engage in abstinence, use a prescription birth control method or use a barrier birth control method while not receiving ART.\n\nExclusion Criteria:\n\n* History of a medical or psychiatric condition that, in the opinion of investigator, would jeopardize the safety or rights of the subject, such as a condition that would interfere with or serve as a contraindication to adherence to the study protocol or ability to give informed consent.","ALL","18 Years",{"count":60,"type":61},100,"ESTIMATED","OBSERVATIONAL","This exploratory study is designed to ensure the safety of HIV-infected volunteers who complete research protocols that include an analytic treatment interruption (ATI). This is a prospective cohort study of volunteers who were diagnosed with HIV during early acute HIV infection, treated with antiretroviral therapy (ART) and subsequently enrolled in a clinical study that included ATI. After completion of study participation that involves ATI, participants will be recruited into this study for continued clinical and laboratory monitoring.",[65],"HIV","2026-04-22",{"date":68,"type":69},"2026-04-27","ACTUAL",{"date":71,"type":10},"2016-03",{"date":73,"type":61},"2031-03",{"name":5,"class":6},1]